Literature DB >> 23290322

Response to past depression treatments is not accurately recalled: comparison of structured recall and patient health questionnaire scores in medical records.

Gregory E Simon1, Carolyn M Rutter, Christine Stewart, Chester Pabiniak, Linda Wehnes.   

Abstract

OBJECTIVE: Assessing response to prior depression treatments is common in research and clinical practice, but few data are available regarding accuracy of patient recall. Data from a population-based survey were linked to electronic medical records to examine agreement between patients' recalled treatment response and depression severity scores in the medical records.
METHOD: Electronic medical records from a large health system identified 1,878 adult patients with 2 or more episodes of clinician-diagnosed major depressive disorder or dysthymia between January 2005 and December 2009 (diagnoses had been recorded using ICD-9 codes). These potential participants were mailed an invitation letter, and, of these, 578 completed an online or mailed survey including structured recall of response to each prior depression treatment, rating both global improvement during treatment and improvement specifically attributed to treatment. For 269 of the survey participants, at least 1 treatment episode could be unambiguously linked to both pretreatment and posttreatment Patient Health Questionnaire (PHQ-9) depression scores in the electronic medical records. Analyses examined the agreement between patients' recall of treatment response and response according to PHQ-9 scores from the medical records.
RESULTS: Agreement between recall and the medical records was poor for both overall improvement following treatment (κ = 0.10; 95% CI, 0.00-0.19) and improvement attributed to treatment (κ = 0.12; 95% CI, 0.00-0.25). Agreement remained poor when the sample was limited to medication treatment episodes, episodes lasting 3 months or more, or episodes for which the participant was "very sure" of his or her ability to recall. Agreement reached a fair level only for episodes in the 6 months prior to the survey, for both overall improvement (κ = 0.23; 95% CI, 0.08-0.39) and improvement attributed to treatment (κ = 0.36; 95% CI, 0.12-0.59).
CONCLUSIONS: Patients' recall of response to past depression treatments agrees poorly with data from medical records. Interview assessment of prior treatment response may not be a useful tool for research or clinical practice. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23290322      PMCID: PMC3711230          DOI: 10.4088/JCP.12m07883

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  17 in total

1.  How accurate is recall of key symptoms of depression? A comparison of recall and longitudinal reports.

Authors:  J Elisabeth Wells; L John Horwood
Journal:  Psychol Med       Date:  2004-08       Impact factor: 7.723

Review 2.  Self-reported utilization of health care services: improving measurement and accuracy.

Authors:  Aman Bhandari; Todd Wagner
Journal:  Med Care Res Rev       Date:  2006-04       Impact factor: 3.929

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians.

Authors:  G E Simon; M Von Korff; C M Rutter; D A Peterson
Journal:  Arch Gen Psychiatry       Date:  2001-04

6.  Recall of recent and more remote depressive episodes in a prospective cohort study.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Andrew G M Bulloch; Carl D'Arcy; David L Streiner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-05-01       Impact factor: 4.328

Review 7.  Personalized medicine for depression: can we match patients with treatments?

Authors:  Gregory E Simon; Roy H Perlis
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

Review 8.  Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research.

Authors:  G E Simon; M VonKorff
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

9.  Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9).

Authors:  Bernd Löwe; Kurt Kroenke; Wolfgang Herzog; Kerstin Gräfe
Journal:  J Affect Disord       Date:  2004-07       Impact factor: 4.839

10.  How accurate are patients in reporting their antidepressant treatment history?

Authors:  Michael A Posternak; Mark Zimmerman
Journal:  J Affect Disord       Date:  2003-07       Impact factor: 4.839

View more
  6 in total

1.  Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.

Authors:  Aimee M Hunter; Ian A Cook; Molly Tartter; Simi K Sharma; Gregory D Disse; Andrew F Leuchter
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

2.  Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age.

Authors:  Soham Rej; Meryl A Butters; Howard J Aizenstein; Amy Begley; Jawad Tsay; Charles F Reynolds; Benoit H Mulsant; Ariel Gildengers
Journal:  Int J Geriatr Psychiatry       Date:  2013-09-05       Impact factor: 3.485

Review 3.  Use of antipsychotic medications in pediatric populations: what do the data say?

Authors:  Robert B Penfold; Christine Stewart; Enid M Hunkeler; Jeanne M Madden; Janet R Cummings; Ashli A Owen-Smith; Rebecca C Rossom; Christine Y Lu; Frances L Lynch; Beth E Waitzfelder; Karen J Coleman; Karen A Coleman; Brian K Ahmedani; Arne L Beck; John E Zeber; Gregory E Simon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP).

Authors:  Boadie W Dunlop; Joanna L Kaye; Cole Youngner; Barbara Rothbaum
Journal:  Behav Sci (Basel)       Date:  2014-12-08

5.  Antidepressant Use by Youth with Minimal or Mild Depression: Evidence from 3 Health Systems.

Authors:  Robert B Penfold; Christine Stewart; Gregory E Simon; Susan M Shortreed; Eric Johnson; Rebecca C Rossom; Belinda Operskalski; Arne Beck
Journal:  Pediatr Qual Saf       Date:  2017-03-22

6.  When Can We Trust Real-World Data To Evaluate New Medical Treatments?

Authors:  Gregory E Simon; Andrew B Bindman; Nancy A Dreyer; Richard Platt; Jonathan H Watanabe; Michael Horberg; Adrian Hernandez; Robert M Califf
Journal:  Clin Pharmacol Ther       Date:  2021-05-28       Impact factor: 6.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.